The Research and Development team at Lava Therapeutics B.V. is dedicated to advancing the science of gamma-delta T-cell engagers (TCEs) for cancer therapy. This multidisciplinary group collaborates on innovative research, conducts bioanalytical assays, and translates preclinical findings into viable therapeutic strategies, driving the discovery and development of novel treatments for cancer patients.